Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Arrowhead Pharmaceuticals Retained Earnings (Accumulated Deficit) 2010-2024 | ARWR

Arrowhead Pharmaceuticals retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  
Arrowhead Pharmaceuticals Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-1,026
2022 $-821
2021 $-645
2020 $-504
2019 $-419
2018 $-487
2017 $-433
2016 $-398
2015 $-317
2014 $-225
2013 $-166
2012 $-135
2011 $-114
2010 $-111
2009 $-105
Arrowhead Pharmaceuticals Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-06-30 $-1,455
2024-03-31 $-1,284
2023-12-31 $-1,159
2023-09-30 $-1,026
2023-06-30 $-916
2023-03-31 $-813
2022-12-31 $-862
2022-09-30 $-821
2022-06-30 $-735
2022-03-31 $-663
2021-12-31 $-708
2021-09-30 $-645
2021-06-30 $-581
2021-03-31 $-551
2020-12-31 $-525
2020-09-30 $-504
2020-06-30 $-455
2020-03-31 $-442
2019-12-31 $-422
2019-09-30 $-419
2019-06-30 $-431
2019-03-31 $-451
2018-12-31 $-475
2018-09-30 $-487
2018-06-30 $-477
2018-03-31 $-461
2017-12-31 $-446
2017-09-30 $-433
2017-06-30 $-422
2017-03-31 $-417
2016-12-31 $-411
2016-09-30 $-398
2016-06-30 $-376
2016-03-31 $-357
2015-12-31 $-336
2015-09-30 $-317
2015-06-30 $-292
2015-03-31 $-276
2014-12-31 $-247
2014-09-30 $-225
2014-06-30 $-202
2014-03-31 $-191
2013-12-31 $-177
2013-09-30 $-166
2013-06-30 $-152
2013-03-31 $-146
2012-12-31 $-140
2012-09-30 $-135
2012-06-30 $-130
2012-03-31 $-122
2011-12-31 $-116
2011-09-30 $-114
2011-06-30 $-111
2011-03-31 $-109
2010-12-31 $-112
2010-09-30 $-111
2010-06-30 $-109
2010-03-31 $-108
2009-12-31 $-107
2009-09-30 $-105
2009-06-30 $-101
2009-03-31 $-99
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.488B $0.241B
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Arrowhead Pharmaceuticals, Inc., formerly known as Arrowhead Research Corporation, is headquartered in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $88.667B 35.33
Takeda Pharmaceutical (TAK) Japan $47.251B 9.46
Merck (MKGAF) Germany $23.748B 25.92
Astellas Pharma (ALPMY) Japan $21.535B 25.87
Summit Therapeutics (SMMT) United States $18.997B 0.00
Sandoz Group AG (SDZNY) Switzerland $17.531B 0.00
United Therapeutics (UTHR) United States $15.350B 15.86
Shionogi (SGIOY) Japan $13.285B 12.73
Neurocrine Biosciences (NBIX) United States $12.350B 36.95
Catalent (CTLT) United States $10.951B 0.00
Orion OYJ (ORINY) Finland $7.373B 30.02
Revolution Medicines (RVMD) United States $7.311B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.889B 7.31
Ionis Pharmaceuticals (IONS) United States $6.069B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.067B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.241B 0.00
Corcept Therapeutics (CORT) United States $4.149B 35.14
Dyne Therapeutics (DYN) United States $3.474B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.733B 15.77
PTC Therapeutics (PTCT) United States $2.698B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.426B 19.28
Soleno Therapeutics (SLNO) United States $2.057B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.900B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.845B 0.00
Xencor (XNCR) United States $1.640B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.639B 0.00
Harrow (HROW) United States $1.546B 0.00
Cassava Sciences (SAVA) United States $1.502B 0.00
Ardelyx (ARDX) United States $1.448B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.391B 0.00
Ocular Therapeutix (OCUL) United States $1.366B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.331B 0.00
Indivior (INDV) United States $1.311B 6.02
Evotec AG (EVO) Germany $1.290B 0.00
ARS Pharmaceuticals (SPRY) United States $1.265B 0.00
Collegium Pharmaceutical (COLL) United States $1.204B 6.91
Calliditas Therapeutics AB (CALT) Sweden $1.199B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.021B 0.00
Relay Therapeutics (RLAY) United States $1.018B 0.00
Enliven Therapeutics (ELVN) United States $1.014B 0.00
Bioventus (BVS) United States $0.921B 29.92
Cronos Group (CRON) Canada $0.864B 0.00
4D Molecular Therapeutics (FDMT) United States $0.840B 0.00
USANA Health Sciences (USNA) United States $0.761B 13.97
Savara (SVRA) United States $0.729B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.716B 44.80
ProKidney (PROK) United States $0.692B 0.00
Pacira BioSciences (PCRX) United States $0.662B 6.26
Corbus Pharmaceuticals Holdings (CRBP) United States $0.613B 0.00
Exscientia (EXAI) United Kingdom $0.608B 0.00
Siga Technologies (SIGA) United States $0.562B 6.74
Silence Therapeutics (SLN) United Kingdom $0.546B 0.00
Foghorn Therapeutics (FHTX) United States $0.544B 0.00
OmniAb (OABI) United States $0.541B 0.00
Altimmune (ALT) United States $0.538B 0.00
Eliem Therapeutics (ELYM) United States $0.534B 0.00
Tourmaline Bio (TRML) United States $0.496B 0.00
Sage Therapeutics (SAGE) United States $0.459B 0.00
KalVista Pharmaceuticals (KALV) United States $0.457B 0.00
Verve Therapeutics (VERV) United States $0.456B 0.00
Aquestive Therapeutics (AQST) United States $0.436B 0.00
Larimar Therapeutics (LRMR) United States $0.435B 0.00
Xeris Biopharma Holdings (XERS) United States $0.432B 0.00
Elite Pharmaceuticals (ELTP) United States $0.409B 38.25
Theravance Biopharma (TBPH) Cayman Islands $0.403B 0.00
Zevra Therapeutics (ZVRA) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.386B 0.00
Lyell Immunopharma (LYEL) United States $0.356B 0.00
Esperion Therapeutics (ESPR) United States $0.349B 0.00
Korro Bio (KRRO) United States $0.347B 0.00
Aldeyra Therapeutics (ALDX) United States $0.343B 0.00
Lexeo Therapeutics (LXEO) United States $0.316B 0.00
ESSA Pharma (EPIX) Canada $0.300B 0.00
Heron Therapeutics (HRTX) United States $0.288B 0.00
Akebia Therapeutics (AKBA) United States $0.288B 0.00
Black Diamond Therapeutics (BDTX) United States $0.273B 0.00
Avita Medical (RCEL) United States $0.267B 0.00
Nature's Sunshine Products (NATR) United States $0.254B 17.35
Enanta Pharmaceuticals (ENTA) United States $0.247B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.241B 0.00
Nektar Therapeutics (NKTR) United States $0.239B 0.00
Nanobiotix S.A (NBTX) France $0.236B 0.00
Acrivon Therapeutics (ACRV) United States $0.235B 0.00
Pyxis Oncology (PYXS) United States $0.213B 0.00
CytoDyn (CYDY) United States $0.205B 0.00
MediWound (MDWD) Israel $0.200B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.188B 0.00
Innate Pharma SA (IPHYF) France $0.184B 0.00
Galectin Therapeutics (GALT) United States $0.173B 0.00
Telomir Pharmaceuticals (TELO) United States $0.166B 0.00
VAXART, INC (VXRT) United States $0.164B 0.00
Context Therapeutics (CNTX) United States $0.156B 0.00
Achieve Life Sciences (ACHV) Canada $0.154B 0.00
Cardiol Therapeutics (CRDL) Canada $0.150B 0.00
Century Therapeutics (IPSC) United States $0.141B 0.00
Prelude Therapeutics (PRLD) United States $0.135B 0.00
OptiNose (OPTN) United States $0.130B 0.00
Fractyl Health (GUTS) United States $0.128B 0.00
Assertio Holdings (ASRT) United States $0.124B 21.67
Incannex Healthcare (IXHL) Australia $0.118B 0.00
CASI Pharmaceuticals (CASI) China $0.107B 0.00
Regulus Therapeutics (RGLS) United States $0.105B 0.00
Journey Medical (DERM) United States $0.105B 0.00
Relmada Therapeutics (RLMD) United States $0.104B 0.00
Metagenomi (MGX) United States $0.103B 0.00
Karyopharm Therapeutics (KPTI) United States $0.094B 0.00
Citius Pharmaceuticals (CTXR) United States $0.091B 0.00
AlloVir (ALVR) United States $0.087B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.077B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.33
Verrica Pharmaceuticals (VRCA) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Nutriband (NTRB) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.060B 0.00
Mural Oncology (MURA) Ireland $0.057B 0.00
ProPhase Labs (PRPH) United States $0.050B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.046B 0.00
Inotiv (NOTV) United States $0.046B 0.00
FibroGen (FGEN) United States $0.045B 0.00
DURECT (DRRX) United States $0.044B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Gain Therapeutics (GANX) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Tempest Therapeutics (TPST) United States $0.038B 0.00
Protara Therapeutics (TARA) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.032B 0.00
Oruka Therapeutics (ORKA) United States $0.032B 0.00
VYNE Therapeutics (VYNE) United States $0.027B 0.00
Surrozen (SRZN) United States $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
Minerva Neurosciences (NERV) United States $0.020B 0.00
Cosmos Health (COSM) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 0.77
TherapeuticsMD (TXMD) United States $0.020B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
BioVie (BIVI) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
NRx Pharmaceuticals (NRXP) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Indaptus Therapeutics (INDP) United States $0.015B 0.00
Talphera (TLPH) United States $0.015B 0.00
Aptorum Group (APM) United Kingdom $0.015B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Conduit Pharmaceuticals (CDT) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.010B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.010B 0.00
Vivos Therapeutics (VVOS) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.58
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.30